Immunohistochemical analyses of patient samples show an increased expression of CXCL8 and its receptors as melanomas transition from a radial (early stage) to vertical (later stage) growth phase [24], with CXCR1 upregulation being a key genetic difference between benign naevi and malignant melanoma [25]. This evidence concerns the gene CXCR1 and melanoma.